Mon, Sep 22, 2014, 8:49 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Curis, Inc. Message Board

  • bestinvestor14 bestinvestor14 Nov 6, 2013 7:09 AM Flag

    Revenues are up though

    Unfortunate thing to happen with the death of a patient but since it is a rising dose MTD defining study they could potentially adjust the dosage with proof of safety margin??? Totally unclear at this point.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I am no expert here. However, there is NO indication of over dosage, It is much more the potential or probably deleterious effects of drug itself among certain patients or patients over time given a particular patient profile. Are there certain contradincators that in certain (few or many, note one is too many) in certain patients that can result in potential death. Never such a simple of a question of well we will just adjust dosage

 
CRIS
1.44-0.08(-5.26%)Sep 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.